Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine vs ropivacaine for postoperative analgesia after total knee arthroplasty
ChiCTR2400082998Phase 4Recruiting
- Sponsor
- Changzhou First People's Hospital
- Start
- Apr 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in disorders of knee and knee osteoarthritis (OA) comparing Liposomal bupivacaine group with Ropivacaine group (2 arms). Primary endpoint: Numerical Rating Scale pain score at 72 hours after surgery. Started Apr 2024; status: recruiting.
02
Drugs
liposomal bupivacaineropivacaine
03
Conditions
disorders of kneeknee osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR2400082998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400082998.